In brief: Singapore’s biotech startup Gero raises US$2.2M Series A

Gero raises funding to develop new drugs for ageing The story: Singapore-based biotech company Gero has secured US$2.2 million in Series A funding, bringing the total capital raised since Gero’s founding to over US$7.5 million. Investors: Bulba Ventures (Belarus), previous investors and serial entrepreneurs in the fields of pharmaceuticals, IT, and AI. Plans with the money: To further […] The post In brief: Singapore’s biotech startup Gero raises US$2.2M Series A appeared first on e27.